Specialty code 183500000X · Vallejo, CA
NPI
1376925479
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
975 Sereno Dr
Vallejo, CA, 94589
Phone (707) 651-5226
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$281K
2,182 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Maria M Hearns-Rivas prescribed most often to Medicare patients was Atorvastatin Calcium, with 350 prescriptions and refills. In total Maria M Hearns-Rivas wrote 2,182 Medicare prescriptions that cost $281K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 350 | 1,157 | 134 | $4,110 |
| Metformin Hcl Er Metformin Hcl | 204 | 670 | 91 | $2,088 |
| Glipizide Generic | 185 | 604 | 78 | $2,382 |
| Insulin Glargine-Yfgn Generic | 126 | 357 | 59 | $19K |
| Metformin Hcl Generic | 112 | 371 | 48 | $1,458 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 106 | 290 | 46 | $2,791 |
| Jardiance Empagliflozin | 98 | 307 | 36 | $56K |
| Humulin N Insulin Nph Human Isophane | 78 | 234 | 44 | $12K |
| Lisinopril Generic | 77 | 257 | 35 | $909 |
| Losartan Potassium Generic | 71 | 234 | 26 | $817 |
| Amlodipine Besylate Generic | 58 | 189 | 22 | $723 |
| Ozempic Semaglutide | 52 | 63 | 18 | $39K |
| Liraglutide Generic | 48 | 52 | 16 | $32K |
| Humulin R Insulin Regular, Human | 45 | 132 | 24 | $7,426 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 42 | 131 | 23 | $1,128 |
Brand drugs: 624 claims; generic drugs: 1,353 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maria M Hearns-Rivas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.